Issue Price
₹100
Per Share
GMP
NIL
Grey Market
Est. Listing
₹100
Expected Price
Min. Application
₹240,000
2 lots × 1200 shares
Incorporated in 1994, Medico Remedies Limited is a WHO-GMP & ISO-9001:2008 certified company engaged in manufacturing and selling of pharmaceutical formulation products in India.The company offers formulation pharmacy products including anti-infective, beta lactum, cephalosporin, antimalarial, antiretroviral, and anti-ulcer drugs, as well as antacids; vitamins, haematinics and other supplements and nonsteroidal anti-inflammatory drugs, antihistaminics, anti-diabetics, cardio vascular drugs, diuretics, anti-epileptics, combination drug kits, syrups and creams and gels.They serves wholesalers or traders of formulation products. The company also exports its products to Uganda, Myanmar, Vietnam, Cambodia, Dominican Republic, Sri Lanka, Philippines, Turkmenistan, Ghana, Mauritius, Madagascar, Congo, Iraq, Honduras, Cuba, Jamaica, Hong Kong, Nigeria, Senegal, Panama, Mozambique etc.
Medico Remedies Ltd. proposes to utilise the net proceeds from the Issue for the following objects:
| Category | Shares Offered | % Issue | Amount (₹ Cr)* | Subscription |
|---|---|---|---|---|
| Market Maker | 57,600 | — | ₹0.58 Cr | — |
| TOTAL | 1,099,200 | 100.00% | ₹10.99 Cr | — |
| Category | Lots | Shares | Amount (₹) |
|---|---|---|---|
| Retail (Min) | 1 | 1,200 | ₹120,000 |
| Retail (Max) | 13 | 15,600 | ₹1,560,000 |
| sNII (Min) | 14 | 16,800 | ₹1,680,000 |
| bNII (Min) | 68 | 81,600 | ₹8,160,000 |
| Particulars | FY 2024-25 | FY 2023-24 | FY 2022-23 |
|---|---|---|---|
| Revenue from Operations | N/A | N/A | N/A |
| EBITDA | N/A | N/A | N/A |
| Profit After Tax (PAT) | N/A | N/A | N/A |
| Net Worth | N/A | N/A | N/A |
| Total Assets | N/A | N/A | N/A |
| Reserves & Surplus | N/A | N/A | N/A |
| Total Borrowings | N/A | N/A | N/A |